Mingze Qin

9PUBLICATIONS
5CO-AUTHORS
Molecular medicineBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
4-Arylindolines Bearing a Pyrido[3,2-<i>d</i>]pyrimidine Scaffold as Dual Inhibitors of the PD-1/PD-L1 Interaction and NAMPT for Targeting Tumor Immunoevasion and Metabolism.

|Nov 28, 2025
Novel Isoidide Subunit-Containing Xanthine Oxidase Inhibitors with Potent Hypouricemic Effects.

Xiaoyi Zeng, Yu Chen, Bing Xu

|Sep 17, 2025
Discovery of Pyrazole-Containing 4‑Arylindolines as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.

Wensong Deng, Yuan Yang, Tairen Zhou

|Apr 29, 2025
Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment.

Wensong Deng, Xuejian Wang, Xinyu Niu

|Mar 06, 2024
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor.

Yuan Yang, Zefei Li, Yidong Wang

|Nov 01, 2023
Agents for the Treatment of Gout: Current Advances and Future Perspectives.

Xiaoyi Zeng, Yajing Liu, Yuxin Fan

Pageof 2

Frequent Collaborators

4 joint publications

Lihui Wang

1 joint publications

Ping Gong

1 joint publications

Simeng Wang

1 joint publications

Jing Tang